$770 Million is the total value of First Light Asset Management, LLC's 63 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Sell | ARRAY BIOPHARMA INC | $54,166,000 | +33.2% | 2,221,721 | -22.1% | 7.04% | +8.6% |
| OMCL | Sell | OMNICELL INC | $42,202,000 | +4.3% | 522,049 | -21.0% | 5.48% | -15.0% |
| NEO | Sell | NEOGENOMICS INC | $32,830,000 | +17.9% | 1,604,611 | -27.3% | 4.27% | -3.9% |
| ATRC | Sell | ATRICURE INC | $24,494,000 | -17.1% | 914,307 | -5.3% | 3.18% | -32.4% |
| VCYT | Sell | VERACYTE INC | $19,330,000 | +0.9% | 772,579 | -49.3% | 2.51% | -17.8% |
| CDXS | Sell | CODEXIS INC | $14,859,000 | -16.0% | 723,760 | -31.7% | 1.93% | -31.5% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $7,272,000 | -47.1% | 188,111 | -61.0% | 0.94% | -56.8% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,948,000 | -10.0% | 18,737 | -43.2% | 0.38% | -26.6% |
| IBB | Sell | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,376,000 | +15.7% | 21,248 | -0.2% | 0.31% | -5.5% |
| PFE | Sell | PFIZER INC | $360,000 | -3.7% | 8,469 | -1.0% | 0.05% | -21.7% |
| MRK | Sell | MERCK & CO INC | $353,000 | +7.6% | 4,247 | -1.1% | 0.05% | -11.5% |
| NVS | Sell | NOVARTIS A G | $340,000 | +10.7% | 3,535 | -1.0% | 0.04% | -10.2% |
| ABBV | Sell | ABBVIE | $332,000 | -13.3% | 4,114 | -1.1% | 0.04% | -29.5% |
| JNJ | Sell | JOHNSON AND JOHNSON | $302,000 | +7.1% | 2,161 | -1.0% | 0.04% | -13.3% |
| SNY | Sell | SANOFI-SYNTHELABO | $294,000 | +0.7% | 6,650 | -1.0% | 0.04% | -19.1% |
| TFX | Sell | TELEFLEX INCORPORATED | $235,000 | +16.3% | 777 | -0.8% | 0.03% | -3.1% |
| ANTM | Sell | ANTHEM INC COM | $228,000 | +8.1% | 795 | -1.0% | 0.03% | -11.8% |
| AMGN | Sell | AMGEN INC | $207,000 | -3.7% | 1,092 | -1.2% | 0.03% | -20.6% |
| PSCH | Exit | INVESCO SMALLCAP HEALTH CARE ETFetf | $0 | – | -17,285 | -100.0% | -0.30% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -98,411 | -100.0% | -0.45% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -512,216 | -100.0% | -0.95% | – |
| SHPG | Exit | SHIRE PLC | $0 | – | -163,409 | -100.0% | -4.53% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.